AKT1 and ovarian carcinoma: These results were strengthened through gain and loss-of-function experiments, since Zhu and colleagues also revealed that exosomal miR-223 could promote drug resistance in epithelial ovarian cancer cells via regulation of PTEN-PI3K/AKT pathways, both in vitro and in vivo.